Franklin Biotechnology Discovery Fund Advisor (FTDZX)
188.22
+1.08
(+0.58%)
USD |
May 08 2026
FTDZX Asset Allocations & Exposures
Asset Allocation
As of March 31, 2026.
| Type | % Net |
|---|---|
| Cash | 2.05% |
| Stock | 94.74% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 1.12% |
| Other | 2.10% |
Market Capitalization
As of March 31, 2026
| Large | 34.46% |
| Mid | 12.52% |
| Small | 53.03% |
Region Exposure
| Americas | 78.45% |
|---|---|
|
North America
|
78.45% |
| Canada | 1.22% |
| United States | 77.23% |
|
Latin America
|
0.00% |
As of March 31, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 17.57% |
|---|---|
| United Kingdom | 1.99% |
|
Europe Developed
|
15.59% |
| Denmark | 2.91% |
| France | 2.23% |
| Germany | 0.23% |
| Ireland | 5.25% |
| Netherlands | 4.38% |
| Sweden | 0.14% |
| Switzerland | 0.45% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 3.98% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
95.85% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
95.85% |
| Utilities |
|
0.00% |
| Not Classified |
|
4.15% |
| Non Classified Equity |
|
1.92% |
| Not Classified - Non Equity |
|
2.23% |
As of March 31, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |